(702) 683-8946

Monday - Friday 9am to 5pm



Buy and register domain names online from CRWE Domains. Web hosting, spam-free email, web marketing, secure SSL Certificates and more




Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com




CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform




Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business




Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.


48 Result: Shire

Shire's First Prescription Eye Drop, Xiidra(TM) (lifitegrast ophthalmic solution) 5% Is Now Available in the U.S.

August 29th, 2016

Xiidra is the onlyprescription eye drop approved by the U.S. FDA for the treatment of both signs and symptoms of dry eye disease Resources are available to support patients seeking information regarding coverage and savings offers Xiidra is t. Read more

Shire Recommends ADS Holders Reject TRC Capital's "Mini-Tender Offer"

July 29th, 2016

Dublin, Ireland / CRWE PRESS RELEASE / July 29, 2016 – Shire plc (LSE: SHP) (NASDAQ: SHPG) has been notified of an unsolicited “mini-tender” offer made by TRC Capital Corporation (“TRC Capital”) to purchase up to 1,000,0. Read more

ONIVYDE(R) Receives Positive CHMP Opinion for Treatment of Patients with Metastatic Adenocarcinoma of the Pancreas who have Progressed Following Gemcitabine based Therapy

July 25th, 2016

The positive opinion is based on a pivotal Phase 3 study showing that ONIVYDE combined with chemotherapy significantly increased overall survival (OS) in patients with metastatic pancreatic cancer after previous gemcitabine based therapy Zug, Swit. Read more

Chronos Therapeutics Acquires Pre-clinical Programmes From Shire

July 20th, 2016

Expands Pipeline With Novel CNS Assets in a Transformative Deal Oxford, UK / CRWE PRESS RELEASE / July 20, 2016 - Chronos Therapeutics Ltd (Chronos), the private biotech company focused on ageing diseases, brain and nervous system disorders, today. Read more

Shire Receives FDA Breakthrough Therapy Designation for SHP621 and SHP625, Investigational Products for Rare Gastrointestinal Conditions

June 13th, 2016

Lexington, Mass. / CRWE PRESS RELEASE / June 13, 2016 – Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for two investigational products for r. Read more

Customers Bank Agrees To Acquire Student Checking Customers And Refund Management Disbursement Business From Higher One, Inc.

December 15th, 2015

Wyomissing, Pa. / CRWEPRESSRELEASE / December 15, 2015 - Customers Bancorp, Inc. ("Customers") (NYSE: CUBI), through its subsidiary Customers Bank announced today that it will acquire the One Account Student Checking and Refund Management Disbur. Read more

FDA approves first drug to treat a rare enzyme disorder in pediatric and adult patients

December 08th, 2015

December 8, 2015 - Today, the U.S. Food and Drug Administration approved Kanuma (sebelipase alfa) as the first treatment for patients with a rare disease known as lysosomal acid lipase (LAL) deficiency. Patients with LAL deficiency (also known as . Read more

Harris Corporation Wins $40 Million Air Force Satellite Control Network Contract Extension

November 10th, 2015

Supports DOD satellites, Air Force Satellite Control Network (AFSCN) and GPS antenna sites Provide operations, maintenance and logistics support Extends company's 19-year relationship with the 50th Space Wing HERNDON. Read more

Shire Receives FDA Complete Response Letter for Lifitegrast NDA and Plans to Respond with OPUS-3 Trial

October 18th, 2015

Topline results from OPUS-3 Trial expected before year-end Lexington, Mass. / CRWEPRESSRELEASE / October 16, 2015 – Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that the U.S. Food and Drug Administration (FDA) requested an additio. Read more

FDA expands approved use of Opdivo in advanced lung cancer

October 11th, 2015

Redistributed by CRWEPRESSRELEASE Opdivo demonstrates survival benefit in squamous and non-squamous non-small cell lung cancer Release Date: October 9, 2015 The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat pat. Read more

Leading Global Bitcoin Adoption, HashingSpace Corporation Uplifts to the OTCQB

July 29th, 2015

US Based Hashingspace Corporation Announced It Has Been Uplifted To A Higher Reporting Status On The OTC Market. Hashingspace Will Now Be Listed As OTCMKTS:HSHS. Hashingspace Provides Scalable Datacenter and Technology Infrastructure for the Global A. Read more

Bitcoin Focused HashingSpace Corporation Announces New Ticker Symbol "HSHS", Files 8-K, and Completes Reverse Merger

July 27th, 2015

  US based HashingSpace Corporation (OTCMKTS:HSHS) is pleased to announce it has completed a reverse merger, and a ticker change from the old ticker MLSOD to HSHS. HashingSpace provides a wide range of services to the Bitcoin and blockchain. Read more

DHS Unveils Major Expansion of Ice Cyber Crimes Center

July 22nd, 2015

Redistributed by CRWEPRESSRELEASE: Release Date: July 22, 2015 New space will offer increased capabilities for ICE to combat cybercrime cases involving underground online marketplaces, child exploitation, intellectual property theft,. Read more

GoPro, Next Galaxy Deepen Roots as Virtual Reality Content Will Be King

July 20th, 2015

REDONDO BEACH, CA / CRWEPRESSRELEASE / July 20, 2105 / Slip on your goggles and watch the actual environment around you morph into a whole new world. Maybe it's a trip to the far reaches of the Antarctic mountains where you begin a search for a missi. Read more

Greek Crisis, Falling Incomes and What it Means for US Investors

July 15th, 2015

WINDSOR, ON / CRWEPRESSRELEASE / July 15 , 2015 / The Radical Consumerist is an Investment Newsletter focused on discovering and showcasing high-yield investment opportunities along with breaking news and analysis geared at maximizing returns for ord. Read more

Load More Content